Pfizer Inc. (PFE) said, in 2021, the company exceeded its goal of manufacturing 3 billion doses of Comirnaty, the Pfizer-BioNTech COVID-19 vaccine. Looking forward, the company increased its 2022 revenue guidance for Comirnaty, reflecting doses expected to be delivered under supply contracts signed as of late-January. Also, the company issued fiscal guidance for the coming year which, if achieved, would represent the highest level of annual revenues and adjusted EPS in its history.
from RTT - Top Story https://ift.tt/S0sc7mQ
via IFTTT
from RTT - Top Story https://ift.tt/S0sc7mQ
via IFTTT
Comments
Post a Comment